This research may shed light on previous data identifying liver-derived IGF-I as one of the main factors in regulating the clearance of brain amyloid-β (Aβ) levels[68] and its potential implications in Alzheimer’s Disease (what will be further discussed in III.4.3). This evidence concerns the gene IGF1 and early-onset autosomal dominant Alzheimer disease.